NR1H3 and metabolic dysfunction-associated steatotic liver disease: Accordingly, we found differential expression of SREBP2, ABCG1c, CROT, FAS, LXRα, PPARδ, and PPARγ in our cohort of patients with MO with or without NAFLD.